🇺🇸 FDA
Company

TENAX

TENAX THERAPEUTICS, INC.

TENX pharma USA

Quick answer

TENAX is a pharma company (TENX) headquartered in CHAPEL HILL, NC, USA with 6 tracked pipeline programs.

Pipeline (6)

project

Levosimendan

Coronary Artery Bypass Grafting

Phase 3 · small_molecule · completed

1 trials project

TNX-103

Pulmonary Hypertension

Phase 3 · small_molecule · active

1 trials project

TNX-103

Pulmonary Hypertension Associated With HFpEF

Phase 3 · small_molecule · active

2 trials project

Levosimendan

Hypertension Pulmonary Secondary

Phase 2 · small_molecule · completed

1 trials project

Levosimendan

Hypertension Pulmonary Secondary Heart Failure

Phase 2 · small_molecule · completed

1 trials project

Oxycyte

Traumatic Brain Injury

Phase 2 · small_molecule · terminated

2 trials

Patents (4)

patent

US 11969424

Levosimendan for treating pulmonary hypertension with heart failure with preserv

Expires Mon Apr 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11701355

Levosimendan for treating pulmonary hypertension with heart failure with preserv

Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11607412

Levosimendan for treating pulmonary hypertension with heart failure with preserv

Expires Mon Mar 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11213524

Pharmaceutical compositions for subcutaneous administration of levosimendan

Expires Mon Dec 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)